The US population counts were estimated using the midpoint of population totals in each NHANES cycle and averaged across combined cycles when appropriate. We accounted for the complex sampling design in all analyses by using sample weights according to National Center for Health Statistics guidelines.
Characteristics of Cluster Randomized Trials: Are They Living Up to the Randomized Trial?
C luster randomized control trials (RCTs) are a form of prospective study where groups of individuals are allocated to an intervention. They offer the unique advantage of rigorously evaluating practices that cannot feasibly be randomized to the individual-such as public health or quality programs. 1 While cluster RCTs can test questions traditional RCTs cannot, the design requires more participants to achieve equivalent statistical power. 1 Over the last decade, the number of cluster RCTs have grown dramatically, 2 but some researchers remain uncertain of how to interpret this study design.
See Editor's Note on page 315 See Editor's Note on page 299
A recent editorial highlights the debate regarding where to place cluster RCTs in the research hierarchy. 3 Two paired articles in a high-impact journal reached different conclusions regarding routine screening and gown and glove precautions for patients with multidrug-resistant bacterial colonization. One article, 4 a quasiexperimental beforeand-after study, found that the practice worked, while another, 5 a multicenter cluster RCT, found no benefit. If an observational study reaches a different result than an RCT, most would conclude the RCT got it right (ie, hormone therapy and cardiovascular risk, beta carotene therapy and cancer prevention). Yet, in the case of contact precautions, the editorial was ambivalent. 3 Ambivalence would be reasonable if cluster RCTs are more likely to reach negative conclusions than RCTs. We sought to examine this hypothesis. Herein, we provide a comparison of cluster RCTs and traditional RCTs for the 50 highest-cited articles (to compare high-impact work) and the most recent 50 articles (to compare a random sampling).
Methods.
We used ISI Web of Science to identify cluster and traditional RCTs based on citation count and date of appearance. Topic and title searches performed for cluster RCTs included the following: cluster randomized trial, cluster randomized controlled trial, cluster randomized study, cluster randomized controlled study, and British spellings of these terms. A similar search strategy was performed for traditional RCTs. We retrieved 200 total articles, split evenly as cluster RCTs and traditional RCTs. Within each of these types, the 50 most highly cited articles and 50 most recent articles were reviewed.
We extracted the following information for each publication: journal name, year of publication, number of times cited, total number of clusters (if applicable), total number of participants, whether the results were positive, whether mortality was examined, and if mortality was positively affected by the intervention. 
74).
When mortality was assessed, the results of highly cited cluster RCTs and traditional RCTs found improved mortality at equal frequency (85% vs 75%; P =.50).
Comment. Cluster RCTs address a gap in contemporary study design, and, to make sense of these trials, it is important to know whether they are comparable to timetested RCTs. Our study demonstrates that cluster RCTs and traditional RCTs achieve the same frequency of positive study findings (both for highly cited work and a random sampling). We provide no evidence to support the belief that cluster RCTs are more likely to reach negative conclusions. Moreover, in the cases where cluster RCT findings are negative, examining the confidence in- terval may clarify the plausible effects of the therapy. If cluster RCTs reach different conclusions than quasiexperimental work, we find no reason why traditional experimental design hierarchies would not apply. Notably, our study found that mortality is less often an end point in highly cited cluster RCTs than in highly cited RCTs. This remains a deficit of this burgeoning methodology. When cluster RCTs do address mortality, however, they reach positive findings as often as traditional RCTs.
In conclusion, if cluster RCTs reach negative conclusions, our study provides no reason to doubt those results. Meanwhile, cluster RCTs should more often assess mortality, a hard and important end point, to match their RCT counterparts.
